Neupogen - 54868-5020-0 - (filgrastim)

Alphabetical Index


Drug Information of Neupogen

Product NDC: 54868-5020
Proprietary Name: Neupogen
Non Proprietary Name: filgrastim
Active Ingredient(s): 300    ug/.5mL & nbsp;   filgrastim
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Neupogen

Product NDC: 54868-5020
Labeler Name: Physicians Total Care, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA103353
Marketing Category: BLA
Start Marketing Date: 20040311

Package Information of Neupogen

Package NDC: 54868-5020-0
Package Description: 10 SYRINGE in 1 BOX (54868-5020-0) > .5 mL in 1 SYRINGE

NDC Information of Neupogen

NDC Code 54868-5020-0
Proprietary Name Neupogen
Package Description 10 SYRINGE in 1 BOX (54868-5020-0) > .5 mL in 1 SYRINGE
Product NDC 54868-5020
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name filgrastim
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20040311
Marketing Category Name BLA
Labeler Name Physicians Total Care, Inc.
Substance Name FILGRASTIM
Strength Number 300
Strength Unit ug/.5mL
Pharmaceutical Classes Granulocyte Colony-Stimulating Factor [Chemical/Ingredient],Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC]

Complete Information of Neupogen


General Information